InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Kharabi Darius, Directeur Commercial. Insider active across 2 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 11 disclosures have been logged. Split: 0 buy · 5 sells. Total volume traded: €57k. History available since 4 January 2023. The latest transaction was filed on 22 October 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kharabi Darius
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
20,806 股@ US$0.8326.1% 占其流量Common StockSEC:0001893729-25-000003:0
4,511 股@ US$4.0136.9% 占其流量Common StockSEC:0001415889-25-018321:0
730 股@ US$3.749.0% 占其流量Common StockSEC:0001415889-25-015681:0
10,100 股0Common StockSEC:0001415889-25-001063:0
5,158 股@ US$4.7594.6% 占其流量Common StockSEC:0001415889-24-018376:0
231 股@ US$6.095.4% 占其流量Common StockSEC:0001415889-24-015225:0
4,600 股0Common StockSEC:0001415889-24-000771:0
36,847 股0Common StockSEC:0001415889-23-010287:0
9 股Common StockSEC:0001415889-23-009138:0
9,525 股0Common StockSEC:0001415889-23-000641:0
295,657 股Common StockSEC:0001415889-21-005280:0
11 条申报中的 11 条
About Kharabi Darius
Kharabi Darius is Directeur Commercial and has reported 11 filings. Across the 11 filings on record, the sampled recent filings show sales only, with total proceeds of EUR 57091, between 2021-11-17 and 2025-10-24, mainly in KALA BIO, Inc. and Kala Pharmaceuticals, Inc.
